Cancer develops when cells in your body accumulate enough DNA damage to override the normal controls on growth and division. This doesn’t happen overnight. It’s a multi-step process that typically unfolds over years or even decades, as cells pick up one mutation after another until they gain the ability to grow without limits, resist death signals, and eventually spread. Understanding each step helps explain why cancer risk rises with age and why certain exposures matter more than others.
It Starts With DNA Damage
Your cells divide billions of times over the course of your life, and each division requires a complete copy of your DNA. Most of the time, your body’s repair systems catch and fix errors. But damage slips through. When faulty repair leads to mutations in the wrong genes, cells can begin behaving abnormally.
DNA damage comes from two broad sources. Internal damage occurs naturally as a byproduct of normal metabolism: your mitochondria produce reactive oxygen species that can alter DNA bases, and spontaneous chemical reactions like hydrolysis constantly chip away at the integrity of your genetic code. External damage comes from physical sources like ultraviolet light and ionizing radiation, or chemical sources like cigarette smoke and industrial chemicals. UV light, for instance, causes specific structural distortions in DNA, while radiation can break both strands of the DNA helix, one of the most dangerous types of damage a cell can sustain.
Your body has multiple repair systems dedicated to fixing each type of damage. The problem isn’t that damage occurs. It’s that over time, some repairs are imperfect, and the errors accumulate. If those errors land in genes that control cell growth, division, or death, the consequences can be serious.
The Two Types of Genes That Matter Most
Not every gene mutation matters for cancer. The ones that do generally fall into two categories: genes that tell cells to grow, and genes that tell cells to stop growing or to die.
The first category involves proto-oncogenes. These are normal genes that help regulate cell division and growth. When a mutation causes a proto-oncogene to become permanently overactive or to produce too many copies of its protein, it becomes an oncogene. It’s like a gas pedal stuck to the floor. The RAS family of genes, for example, stimulates several pathways that drive cell proliferation. The MYC gene promotes cell division through a protein that directly influences how DNA is read. When these genes malfunction, cells multiply far beyond what the body needs.
The second category is tumor suppressor genes, which act as brakes. They produce proteins that slow cell division, activate DNA repair, or trigger programmed cell death (apoptosis) when something goes wrong. The p53 gene is one of the most important: it detects DNA damage and either pauses the cell cycle so repairs can happen or orders the cell to self-destruct. Another, the Rb gene, controls the checkpoint between phases of cell division. When tumor suppressors are knocked out by mutations, cells lose the ability to stop themselves from dividing, and damaged cells that should have been eliminated survive instead.
Cancer typically requires mutations in both categories. A cell with just an overactive growth signal might still be held in check by its tumor suppressors, and a cell that loses one brake might not proliferate if its growth signals are normal. It’s the combination that becomes dangerous.
Most Cancer Is Not Inherited
About 75% to 80% of cancers are sporadic, meaning the mutations that cause them are acquired during a person’s lifetime rather than passed down from a parent. These mutations exist only in the tumor cells and aren’t present in the rest of the body.
Only 5% to 10% of all cancers are truly hereditary, caused by a gene mutation present from birth. People with inherited mutations in DNA repair genes, for instance, start life with one layer of protection already compromised, which elevates their susceptibility to specific cancer types. But even in hereditary cases, additional mutations acquired over time are usually necessary before cancer actually develops. An inherited mutation loads the dice; it doesn’t guarantee the outcome.
Changes Beyond the DNA Sequence
Mutations aren’t the only way genes go wrong. Epigenetic changes alter how genes are read without changing the underlying DNA code, and they play a significant role in cancer development.
The most studied mechanism is DNA methylation, a chemical tag that cells place on certain genes to silence them. In cancer cells, the pattern of these tags is disrupted in two ways. First, tumor suppressor genes can be inappropriately silenced by excessive methylation at their control regions, shutting down the very genes meant to prevent uncontrolled growth. Second, other regions of the genome lose methylation they normally have, which can activate oncogenes that should be quiet and destabilize the genome overall. This combination gives tumor cells a growth advantage and increases their genetic instability, making further harmful mutations more likely.
Modifications to histones, the proteins that DNA wraps around, also matter. By altering the physical structure of how DNA is packaged, cells can make certain genes more or less accessible. In cancer, these modifications frequently shift toward patterns that promote growth and suppress cell death. Unlike mutations, many epigenetic changes are potentially reversible, which is one reason researchers are interested in therapies that target them.
Chronic Inflammation Fuels the Process
Long-term inflammation creates an environment where cancer is more likely to develop. When tissues stay inflamed for months or years, whether from infection, autoimmune conditions, or ongoing irritation, the body produces signaling molecules called cytokines that were meant to coordinate healing but instead promote tumor-friendly conditions.
Pro-inflammatory cytokines that are overproduced during chronic inflammation drive cell proliferation, help new blood vessels form to feed growing tissue, and help cells survive when they normally wouldn’t. At the same time, anti-inflammatory cytokines can suppress the immune system’s ability to detect and destroy abnormal cells. The sustained activation of certain signaling pathways in this environment pushes gene expression toward cell survival and immune evasion. This is why conditions that cause persistent inflammation, such as chronic hepatitis, inflammatory bowel disease, or long-term infection with certain bacteria, are recognized risk factors for specific cancers.
How Tumors Hide From Your Immune System
Your immune system routinely detects and destroys abnormal cells. For a tumor to grow, it has to find ways around this surveillance. Cancer cells use several strategies to do this.
Some tumors shed or reduce the surface markers that immune cells use to identify threats. Without these markers, T cells (the immune system’s primary killers) can’t recognize the cancer cells as abnormal. Other tumors release chemical signals that prevent immune cells from maturing or migrating to the tumor site. Perhaps most importantly, tumors can exhaust the T cells that do manage to infiltrate. These T cells end up expressing multiple “off-switch” receptors on their surface, effectively shutting down in the presence of the cancer they’re supposed to fight.
This process of immune evasion explains why cancer can develop even in people with healthy immune systems. The tumor doesn’t have to overpower immunity all at once. It just has to evolve enough tricks, one mutation or adaptation at a time, to tip the balance.
Becoming Immortal: Bypassing Cell Death
Normal cells have a built-in limit on how many times they can divide. Each time a cell copies itself, the protective caps on the ends of its chromosomes (called telomeres) get a little shorter. Eventually they become too short, and the cell either stops dividing or self-destructs. This process, called cellular senescence, is one of the body’s most important defenses against runaway growth.
Cancer cells bypass this limit. Many do it by reactivating an enzyme called telomerase, which rebuilds the chromosome caps after each division, effectively making the cell immortal. Others suppress the very proteins, like p53 and p27, that enforce senescence. Some cancer cells that have been pushed into a senescent state by the body’s defenses or by treatment can actually re-enter the cell cycle and start dividing again, which contributes to treatment resistance and recurrence.
Why It Takes So Long
Cancer is rarely caused by a single event. A cell needs to acquire the ability to grow without external signals, ignore stop signals, avoid immune detection, resist cell death, build its own blood supply, and eventually invade other tissues. Each of these capabilities typically requires separate genetic or epigenetic changes, and most of those changes take time to accumulate.
This is why cancer incidence rises sharply with age. A 70-year-old’s cells have had decades more exposure to both internal and external sources of DNA damage than a 20-year-old’s. It’s also why strong risk factors like smoking, chronic infection, and radiation exposure increase cancer rates: they accelerate the accumulation of mutations. And it explains why people with inherited mutations in repair genes tend to develop cancer earlier in life, because they start the process already partway down the path.
The multi-step nature of cancer development also means that the body has many opportunities to stop the process. Most pre-cancerous cells are caught and eliminated long before they become dangerous. Cancer develops when enough of those safeguards fail in the same cell lineage, a statistically unlikely event that nonetheless happens millions of times a year worldwide because of the sheer number of cell divisions occurring in every human body, every day.